{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:51:47Z","timestamp":1791841907090,"version":"4.3.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018583","name":"Wuhan Science and Technology Bureau","doi-asserted-by":"publisher","award":["2020020601012241"],"award-info":[{"award-number":["2020020601012241"]}],"id":[{"id":"10.13039\/501100018583","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Breast cancer (BC) is the most common malignancy and the leading cause of cancer-related death among women worldwide. Early detection, treatment, and metastasis monitoring are very important for the prognosis of BC patients. Therefore, effective biomarkers need to be explored to help monitor the prognosis of BC patients and guide treatment decisions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, the relationship between CCDC69 expression levels and tumor clinical characteristics were analyzed using RNA-seq information in BC samples from the TCGA database. Kaplan-Meier survival analysis was performed to analyze the prognostic value of CCDC69 in BC patients. Besides, gene enrichment analysis in BC samples was used to confirm the main function of CCDC69 in BC. The correlation between the expression of CCDC69 and the number of tumor-infiltrating lymphocytes was confirmed by interaction analysis of TIMER and GEPIA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results showed that CCDC69 expression was significantly lower in cancer samples than in normal tissues, and was significantly lower in highly invasive BC than in carcinoma <jats:italic>in situ<\/jats:italic>. Meanwhile, low levels of CCDC69 were associated with a further poor prognosis. CDCC69 expression was positively correlated with the amount of different tumor-infiltrating lymphocytes. Mechanically, it could be presumed that the low expression of CCDC69 in BC might be caused by hypermethylation of the promoter region.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Summarily, CDCC69 could be used as a potential biomarker to predict the prognosis of BC and the sensitivity to immunotherapy such as PD-1\/PD-L1 checkpoint inhibitors.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2022.879921","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T06:16:00Z","timestamp":1657865760000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["CCDC69 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration"],"prefix":"10.3389","volume":"9","author":[{"given":"Yi","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000477851","article-title":"Tumour heterogeneity of breast cancer: from morphology to personalised medicine","volume":"85","author":"Aleskandarany","year":"2018","journal-title":"Pathobiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"24174","DOI":"10.1074\/jbc.M112.343764","article-title":"Coiled coil domain-containing protein 56 (CCDC56) is a novel mitochondrial protein essential for cytochrome c oxidase function","volume":"287","author":"Peralta","year":"2012","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.18632\/oncotarget.6709","article-title":"Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma","volume":"7","author":"Yin","year":"2016","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.humpath.2016.06.001","article-title":"Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non\u2013small cell lung cancer cells","volume":"56","author":"Jiang","year":"2016","journal-title":"Hum Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1038\/onc.2014.357","article-title":"Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma","volume":"34","author":"Radulovich","year":"2015","journal-title":"Oncogene"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.4161\/cc.9.20.13387","article-title":"Role of a novel coiled-coil domain-containing protein CCDC69 in regulating central spindle assembly","volume":"9","author":"Pal","year":"2010","journal-title":"Cell Cycle"},{"key":"B8","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.18632\/oncotarget.21356","article-title":"Inhibition of coiled coil domain containing protein 69 enhances platinum-induced apoptosis in ovarian cancer cells","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13048-019-0479-3","article-title":"Overexpression of CCDC69 activates p14ARF\/MDM2\/p53 pathway and confers cisplatin sensitivity","volume":"12","author":"Cui","year":"2019","journal-title":"J Ovarian Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1186\/s12864-019-6412-8","article-title":"Putative biomarkers for predicting tumor sample purity based on gene expression data","volume":"20","author":"Li","year":"2019","journal-title":"BMC Genomics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"555865","DOI":"10.3389\/fgene.2020.555865","article-title":"Identification of tumor microenvironment-related prognostic biomarkers in luminal breast cancer","volume":"11","author":"Wang","year":"2020","journal-title":"Front Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12935-020-01175-1","article-title":"Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer","volume":"20","author":"Gao","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1038\/s41598-018-27521-y","article-title":"Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets","volume":"8","author":"Nagy","year":"2018","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0179726","DOI":"10.1371\/journal.pone.0179726","article-title":"Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors","volume":"12","author":"Siemers","year":"2017","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"181ra50-181ra50","DOI":"10.1126\/scitranslmed.3005974","article-title":"Development of a prognostic model for breast cancer survival in an open challenge environment","volume":"5","author":"Cheng","year":"2013","journal-title":"Sci Transl Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e19230","DOI":"10.1097\/MD.0000000000019230","article-title":"Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer","volume":"99","author":"Xing","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s40425-019-0770-2","article-title":"Mechanisms regulating PD-L1 expression on tumor and immune cells","volume":"7","author":"Chen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.4049\/jimmunol.169.10.5538","article-title":"Expression of programmed death 1 ligands by murine T cells and APC","volume":"169","author":"Yamazaki","year":"2002","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti\u2013PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/jamaoncol.2018.7147","article-title":"Current landscape of immunotherapy in breast cancer","volume":"5","author":"Adams","year":"2019","journal-title":"JAMA Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/S1470-2045(19)30026-9","article-title":"Immunotherapy and targeted therapy combinations in metastatic breast cancer","volume":"20","author":"Esteva","year":"2019","journal-title":"Lancet Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"127ps8-127ps8","DOI":"10.1126\/scitranslmed.3003634","article-title":"Raising the bar: the curative potential of human cancer immunotherapy","volume":"4","author":"Rosenberg","year":"2012","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/0959-8049(92)90134-N","article-title":"Lymphocyte infiltrates as a prognostic variable in female breast cancer","volume":"28","author":"Aaltomaa","year":"1992","journal-title":"Eur J Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/ajcp\/26.3.250","article-title":"Structural representations of tumor-host relationships in mammary carcinoma: biologic and prognostic significance","volume":"26","author":"Black","year":"1956","journal-title":"Am J Clin Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1158\/0008-5472.CAN-12-4241","article-title":"Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity","volume":"73","author":"Kang","year":"2013","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/annonc\/mdv239","article-title":"Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials","volume":"26","author":"Dieci","year":"2015","journal-title":"Ann Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamaoncol.2018.4224","article-title":"Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer","volume":"5","author":"Emens","year":"2019","journal-title":"JAMA Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10549-017-4537-5","article-title":"Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study","volume":"167","author":"Dirix","year":"2018","journal-title":"Breast Cancer Res Treat"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.879921\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T06:16:03Z","timestamp":1657865763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.879921\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":33,"alternative-id":["10.3389\/fsurg.2022.879921"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2022.879921","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"article-number":"879921"}}